Corticotropin releasing factor impairs sustained attention in male and female rats

Behavioural Brain Research

Volumn 296, Issue , 2016, Pages 30-34

  Cole, Robert D ^a   Kawasumi, Yushi ^a   Parikh, Vinay ^a   Bangasser, Debra A ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Cognition; Corticotropin releasing hormone; Estrous cycle; Sex difference; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; OVARY PEPTIDE HORMONE;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATTENTION; ATTENTION DISTURBANCE; ATTENTION TEST; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; HORMONAL REGULATION; HORMONE RELEASE; MALE; NONHUMAN; OPERANT SUSTAINED ATTENTION TASK; PRIORITY JOURNAL; PROESTRUS; RAT; REGULATORY MECHANISM; SEX DIFFERENCE; STRESS; SUSTAINED ATTENTION; TASK PERFORMANCE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; MENTAL STRESS; METABOLISM; PSYCHOMOTOR PERFORMANCE; SPRAGUE DAWLEY RAT;

ANIMALS; ATTENTION; BEHAVIOR, ANIMAL; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROUS CYCLE; FEMALE; MALE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; STRESS, PSYCHOLOGICAL;

EID: 84940502509     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.08.023     Document Type: Article

References (25)

1. Hancock P.A., Warm J.S. A dynamic model of stress and sustained attention. Human Factors 1989, 31:519-537.
2. Paelecke-Habermann Y., Pohl J., Leplow B. Attention and executive functions in remitted major depression patients. J. Affective Disorders 2005, 89:125-135.
3. Vasterling J.J., Brailey K., Constans J.I., Sutker P.B. Attention and memory dysfunction in posttraumatic stress disorder. Neuropsychology 1998, 12:125-133.
4. Sarter M., Givens B., Bruno J.P. The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Res. Brain Res. Rev. 2001, 35:146-160.
5. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 2004, 44:525-557.
6. Van Bockstaele E.J., Peoples J., Valentino R.J., Bennett A.E. Research award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biol. Psychiatry 1999, 46:1352-1363.
7. Banki C.M., Karmacsi L., Bissette G., Nemeroff C.B. CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse. Eur. Neuropsychopharmacol.: J. Eur. College Neuropsychopharmacol. 1992, 2:107-113.
8. Bremner J.D., Licinio J., Darnell A., Krystal J.H., Owens M.J., Southwick S.M., et al. Elevated corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am. J. Psychiatry 1997, 154:624-629.
9. Gold P.W., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 2002, 7:254-275.
10. Bangasser D.A., Kawasumi Y. Cognitive disruptions in stress-related psychiatric disorders: a role for corticotropin releasing factor (CRF). Horm. Behav. 2015, In press.
11. Demeter E., Sarter M., Lustig C. Rats and humans paying attention: cross-species task development for translational research. Neuropsychology 2008, 22:787-799.
12. McGaughy J., Kaiser T., Sarter M. Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav. Neurosci. 1996, 110:247-265.
13. Bangasser D.A., Curtis A., Reyes B.A., Bethea T.T., Parastatidis I., Ischiropoulos H., et al. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol. Psychiatry 2010, 15(877):96-904.
14. Bangasser D.A., Reyes B.A., Piel D., Garachh V., Zhang X.Y., Plona Z.M., et al. Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression. Mol. Psychiatry 2013, 18:166-173.
15. Snyder K., Wang W.W., Han R., McFadden K., Valentino R.J. Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility. Neuropsychopharmacology 2012, 37:520-530.
16. Parikh V., Howe W.M., Welchko R.M., Naughton S.X., D'Amore D.E., Han D.H., et al. Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging. Eur. J. Neurosci. 2013, 37:278-293.
17. Bangasser D.A., Lee C.S., Cook P.A., Gee J.C., Bhatnagar S., Valentino R.J. Manganese-enhanced magnetic resonance imaging (MEMRI) reveals brain circuitry involved in responding to an acute novel stress in rats with a history of repeated social stress. Physiol. Behav. 2013, 122:228-236.
18. Van't Veer A., Yano J.M., Carroll F.I., Cohen B.M., Carlezon W.A. Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the kappa-opioid receptor antagonist JDTic. Neuropsychopharmacology 2012, 37:2809-2816.
19. van Gaalen M.M., Stenzel-Poore M., Holsboer F., Steckler T. Reduced attention in mice overproducing corticotropin-releasing hormone. Behav. Brain Res. 2003, 142:69-79.
20. Gill T.M., Sarter M., Givens B. Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation. J. Neurosci. 2000, 20:4745-4757.
21. Sauvage M., Steckler T. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei-potential implication for arousal and attention. Neuroscience 2001, 104:643-652.
22. Burk J.A., Sarter M. Dissociation between the attentional functions mediated via basal forebrain cholinergic and GABAergic neurons. Neuroscience 2001, 105:899-909.
23. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 2000, 428:191-212.
24. McGaughy J., Sarter M. Effects of ovariectomy, 192 IgG-saporin-induced cortical cholinergic deafferentation, and administration of estradiol on sustained attention performance in rats. Behav. Neurosci. 1999, 113:1216-1232.
25. Popovic D., Vieta E., Fornaro M., Perugi G. Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants. J. Affective Disorders 2015, 173:211-215.